Skip to main content
. 2021 Jul 14;8:691907. doi: 10.3389/fcvm.2021.691907

Figure 4.

Figure 4

Forest plot depicting the relative risk (RR) according to the administered type of SGLT2 inhibitor for (A) cardiovascular (CV) mortality alone and (B) all-cause mortality.